Indeed, this TRPV1 agonist-induced analgesia has been observed in humans, as topical capsaicin application has long been used by some patients as a treatment for arthritis pain, and a review on this topic identified a number-needed-to-treat of only 3.3 for a 50% reduction in pain [66]. The gene discussed is TRPV1; the disease is arthritic joint disease.